Humacyte (HUMA) Current Assets (2020 - 2026)
Humacyte (HUMA) reported Current Assets of $92.79 million for Q2 2026, up 79.4% from $51.73 million a year earlier and up 45.9% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Humacyte posted Current Assets of $67.8 million, up 41.7% from FY2024.
- Current Assets has a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
- By year, Current Assets came in at $47.86 million in FY2024 (-42.5%), $83.28 million in FY2023 (-46.0%), $154.21 million in FY2022 (-32.8%) and $229.34 million in FY2021 (+453.3%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q2 2024.
- Year over year, Current Assets gained in three of the last eight quarters, with an average decline of 2.1%.
- The high point for year-over-year Current Assets in five years was Q4 2021 (growth of 453.3%); the low point was Q3 2024 (a decline of 77.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $63.6 million (Q1 2026), $67.8 million (Q4 2025) and $41.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.58 Bn | 1,139.17 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 639.26 Bn | 557.79 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 501.86 Bn | 474.97 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 374.72 Bn | 329.10 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 302.72 Bn | 266.71 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 268.40 Bn | 242.08 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 242.11 Bn | 197.51 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 193.45 Bn | 167.65 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 172.31 Bn | 118.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Humacyte | 95.24 Mn | -103.20 Mn | -825,000.00 | 92.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.79 Mn |
| Mar 31, 2026 | 63.60 Mn |
| Dec 31, 2025 | 67.80 Mn |
| Sep 30, 2025 | 41.35 Mn |
| Jun 30, 2025 | 51.73 Mn |
| Mar 31, 2025 | 73.71 Mn |
| Dec 31, 2024 | 47.86 Mn |
| Sep 30, 2024 | 23.01 Mn |
| Jun 30, 2024 | 96.11 Mn |
| Mar 31, 2024 | 117.93 Mn |
| Dec 31, 2023 | 83.28 Mn |
| Sep 30, 2023 | 102.85 Mn |
| Jun 30, 2023 | 120.56 Mn |
| Mar 31, 2023 | 133.86 Mn |
| Dec 31, 2022 | 154.21 Mn |
| Sep 30, 2022 | 174.61 Mn |
| Jun 30, 2022 | 193.03 Mn |
| Mar 31, 2022 | 209.30 Mn |
| Dec 31, 2021 | 229.34 Mn |
| Sep 30, 2021 | 244.18 Mn |
API Access
Humacyte Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();